社区获得性肺炎
医学
肺炎
铜绿假单胞菌
肺炎链球菌
抗生素
支气管扩张
病因学
重症监护医学
菌血症
微生物学
内科学
细菌
生物
遗传学
肺
作者
Luís Coelho,Ana Sofia Pais
标识
DOI:10.1016/j.amjms.2023.04.013
摘要
Community acquired pneumonia (CAP) is a leading infectious cause of morbidity and mortality worldwide. Several viruses and bacteria cause CAP but Streptococcus pneumoniae remains the most frequently identified bacterial pathogen. 1 Restrepo MI Babu BL Reyes LF et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018; 52 Google Scholar Prognosis depends on several factors including age, comorbidities, microbial aetiology and early and adequate initial antibiotic treatment. Initial antibiotic treatment is frequently administered on an empirical basis covering the most common microorganisms. Some gram-negative bacilli namely the Enterobacteriaceae family and Pseudomonas aeruginosa are rare causes of CAP and are frequently resistant to the initial empirical treatment. Both microorganisms are associated with severe CAP and higher mortality due to its aggressive behaviour and the delay in the initiation of the appropriate antibiotic coverage. 2 Torres A Menendez R. Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?. Eur Respir J. 2010; 35: 473-474 Google Scholar
科研通智能强力驱动
Strongly Powered by AbleSci AI